Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives

被引:28
作者
Bhat, Mashooq Ahmad [1 ]
Al-Omar, Mohamed A. [1 ]
Naglah, Ahmed M. [2 ,3 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Coll Pharm, DEDC, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
[3] Natl Res Ctr, Chem Ind Res Div, Peptide Chem Dept, Cairo, Egypt
关键词
Dihydropyrimidinone; piperidine; anti-ulcer; cytoprotective; BLOCKERS; AGENTS;
D O I
10.1080/14756366.2018.1474212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dihydropyrimidinone derivatives containing piperidine moiety were synthesised in a good yield. All the compounds were confirmed by elemental analysis and spectral data. Anti-ulcer activity of novel dihydropyrimidinone-piperidine hybrids (1-18) was evaluated. Among them, four compounds (3, 8, 11 and 15) were found to be most active in 80% ethanol-induced ulcer experimental animal model. All the potent compounds were further evaluated for anti-ulcer activity by different in vivo anti-ulcer models to study the effect of compounds on anti-secretory and cytoprotective activities. All the active compounds inhibited the formation of gastric ulcers and increased the formation of gastric mucin secretion. Compound 15 was found to be the most potent compound of the series as anti-ulcer agent. Additional experimental studies on lead compound 15 will result in a new class of orally active molecule for anti-ulcer activity.
引用
收藏
页码:978 / 988
页数:11
相关论文
共 31 条
[1]   MISOPROSTOL COMPARED WITH SUCRALFATE IN THE PREVENTION OF NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED GASTRIC-ULCER - A RANDOMIZED, CONTROLLED TRIAL [J].
AGRAWAL, NM ;
ROTH, S ;
GRAHAM, DY ;
WHITE, RH ;
GERMAIN, B ;
BROWN, JA ;
STROMATT, SC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) :195-200
[2]   Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies [J].
Ahn, Jeong Soo ;
Eom, Chun-Sick ;
Jeon, Christie Y. ;
Park, Sang Min .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (16) :2560-2568
[3]   DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS .3. 3-CARBAMOYL-4-ARYL-1,2,3,4-TETRAHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS ORALLY EFFECTIVE ANTIHYPERTENSIVE AGENTS [J].
ATWAL, KS ;
SWANSON, BN ;
UNGER, SE ;
FLOYD, DM ;
MORELAND, S ;
HEDBERG, A ;
OREILLY, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :806-811
[4]   DIHYDROPYRIMIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].
ATWAL, KS ;
AHMED, SZ ;
BIRD, JE ;
DELANEY, CL ;
DICKINSON, KEJ ;
FERRARA, FN ;
HEDBERG, A ;
MILLER, AV ;
MORELAND, S ;
OREILLY, BC ;
SCHAEFFER, TR ;
WALDRON, TL ;
WELLER, HN .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (25) :4751-4763
[5]  
Beena KP, 2016, J PHARM SCI RES, V8, P741
[6]   MECHANISM OF ULCEROGENIC ACTIVITY OF INDOMETHACIN AND OXYPHENBUTAZONE [J].
BHARGAVA, KP ;
GUPTA, MB ;
TANGRI, KK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 22 (02) :191-195
[7]   Synthesis, anti-inflammatory and neuroprotective activity of pyrazole and pyrazolo[3,4-d]pyridazine bearing 3,4,5-trimethoxyphenyl [J].
Bhat, Mashooq A. ;
Ahmed, Atallah F. ;
Wen, Zhi-Hong ;
Al-Omar, Mohamed A. ;
Abdel-Aziz, Hatem A. .
MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (07) :1557-1566
[8]  
Bhat MA, 2012, LETT ORG CHEM, V9, P487
[9]   Targeting Cancer Stem Cells with Novel 4-(4-Substituted phenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thiones [J].
Bhat, Mashooq Ahmad ;
Al-Dhfyan, Abdullah ;
Al-Omar, Mohamed A. .
MOLECULES, 2016, 21 (12)
[10]  
CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116